Adductor spasmodic dysphonia: Botulinum toxin a injections or laser thyroarytenoid myoneurectomy? A comparison from the patient perspective

OBJECTIVES/HYPOTHESIS: The current gold standard of therapy for adductor spasmodic dysphonia (AdSD) is injection of botulinum toxin A (BTX) in the adductor musculature. A surgical procedure could potentially offer more stable and long‐lasting voice quality. In this study, we report the long‐term res...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuering, Juliëtta H. C., Heijnen, Bas J., Sjögren, Elisabeth V., Langeveld, Antonius P. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Laryngology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065196/
https://www.ncbi.nlm.nih.gov/pubmed/31169922
http://dx.doi.org/10.1002/lary.28105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065196/
https://www.ncbi.nlm.nih.gov/pubmed/31169922
http://dx.doi.org/10.1002/lary.28105

Ejemplares similares